Cargando…
Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330778/ https://www.ncbi.nlm.nih.gov/pubmed/32642225 http://dx.doi.org/10.21037/jtd-20-2011 |
| _version_ | 1783553194331209728 |
|---|---|
| author | Ramnath, Venktesh R. Zar, Heather J. Malhotra, Atul |
| author_facet | Ramnath, Venktesh R. Zar, Heather J. Malhotra, Atul |
| author_sort | Ramnath, Venktesh R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7330778 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73307782020-07-07 Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 Ramnath, Venktesh R. Zar, Heather J. Malhotra, Atul J Thorac Dis Editorial AME Publishing Company 2020-06 /pmc/articles/PMC7330778/ /pubmed/32642225 http://dx.doi.org/10.21037/jtd-20-2011 Text en 2020 Journal of Thoracic Disease. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Ramnath, Venktesh R. Zar, Heather J. Malhotra, Atul Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 |
| title | Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 |
| title_full | Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 |
| title_fullStr | Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 |
| title_full_unstemmed | Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 |
| title_short | Addressing the “What do we have to lose? Just give the drug” rationale: making the case for clinical trials and against off-label use in COVID-19 |
| title_sort | addressing the “what do we have to lose? just give the drug” rationale: making the case for clinical trials and against off-label use in covid-19 |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330778/ https://www.ncbi.nlm.nih.gov/pubmed/32642225 http://dx.doi.org/10.21037/jtd-20-2011 |
| work_keys_str_mv | AT ramnathvenkteshr addressingthewhatdowehavetolosejustgivethedrugrationalemakingthecaseforclinicaltrialsandagainstofflabeluseincovid19 AT zarheatherj addressingthewhatdowehavetolosejustgivethedrugrationalemakingthecaseforclinicaltrialsandagainstofflabeluseincovid19 AT malhotraatul addressingthewhatdowehavetolosejustgivethedrugrationalemakingthecaseforclinicaltrialsandagainstofflabeluseincovid19 |